Jillian Brooke Morse, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 550 W Western Ave, Suite B, Muskegon, MI 49440 Phone: 231-726-4498 |
Bianca Fields, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 |
Susan L Ertzinger, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 |
Anna Frey, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 |
Jennifer J Conner, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 |
Boyd J. Colbry, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-739-3928 |
Rebecca Thomas, N.P. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr Ste 100, Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-5212 |
News Archive
Oregon Health & Science University Cancer Institute researchers have identified a protein fragment in some human breast cancers that may help predict a patient's chances of survival.
For some patients undergoing intestinal or multi-organ transplantation, closing the abdominal wall poses a difficult surgical challenge.
The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing. Research published today in the open access journal BMC Bioinformatics shows scientists how to monitor alternative splicing activity on a genome-wide scale, without investing in new exon microarray technologies.
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at The University of Texas MD Anderson Cancer Center have discovered a particularly high prevalence of hereditary cancers among those diagnosed with the disease before the age of 35. They suggest that these patients should undergo genetic counseling to determine if their families may be at an elevated risk.
› Verified 7 days ago